Abstract
Background Metabolic syndrome (MetS) is a complex condition encompassing a constellation of cardiometabolic abnormalities. Integratively phenotyping the molecular pathways involved in MetS would help to deeply characterize its pathophysiology and to better stratify the risk of cardiometabolic diseases. Oxylipins are a superfamilly of lipid mediators regulating most biological processes involved in cardiometabolic health.
Methods A high-throughput validated mass spectrometry method allowing the quantitative profiling of over 130 oxylipins was applied to identify and validate the oxylipin signature of MetS in two independent case/control studies involving 476 participants.
Results We have uncovered and validated an oxylipin signature of MetS (coined OxyScore) including 23 oxylipins and having high performances of classification and replicability (cross-validated AUCROC of 89%, 95% CI: 85%-93% and 78%, 95% CI: 72%-85% in the Discovery and Replication studies, respectively). Correlation analysis and comparison with a classification model incorporating both the oxylipins and the MetS criteria showed that the oxylipin signature brings consistent and complementary information supporting its clinical utility. Moreover, the OxyScore provides a unique mechanistic signature of MetS regarding the activation and/or negative feedback regulation of crucial molecular pathways that may help identify patients at higher risk of cardiometabolic diseases.
Conclusion Oxylipin profiling identifies a mechanistic signature of metabolic syndrome that may help to enhance MetS phenotyping and ultimately to better predict the risk of cardiometabolic diseases via a better patient stratification.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by national research agencies: French grant ANR.16.HDHL.0004.01/02, German BMBF grant 01EA1702, Danish grant 4203.00006B and Polish grant ERAH.E220.18.001 in the framework of the Oxygenate project supported by the European Joint Programming Initiative A Healthy Diet for a Healthy Life (JPI HDHL). And USDA CRIS Project 2032.51530.025.00D.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
PURE study was approved by the Institutional Review Board of the Wroclaw Medical University (IRB number: KB-443/2006). NutriNet-Sante study was approved by the International Research Board of the French Institute of Health and Medical research (IRB Inserm nb 0000388FWA00005831) and the Comite National Informatique et Liberte (CNIL 908450 and 909216).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† equally contributed
Funding sources National research agencies: (i) French (grant N° ANR-16-HDHL-0004-01/02), (ii) German (BMBF grant N°01EA1702), (iii) Danish (grant N° 4203 – 00006B) and (iv) Polish (grant N° ERAH.E220.18.001) in the framework of the Oxygenate project supported by the European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL). And USDA CRIS Project 2032-51530-025-00D.
Data Availability
All data produced in the present study are available upon reasonable request to the corresponding author
Abbreviations
- AA
- arachidonic acid
- AHEI
- alternative healthy eating index
- ALA
- α-linolenic acid
- AUCROC
- area under the receiver operating characteristic curves
- BH
- Benjamini-Hochberg
- BHT
- butylated hydroxytoluene
- BMI
- body mass index
- BP
- blood pressure
- CAD
- coronary artery disease
- COX
- cyclooxygenase
- CYP
- cytochrome P450
- DGLA
- dihomo-γ-linolenic acid
- DHA
- docosahexaenoic acid
- EDTA
- Ethylenediaminetetraacetic acid
- EPA
- eicosapentaenoic acid
- FAMEs
- fatty acids methyl esters
- FFQ
- food frequency questionnaire
- GC
- gas chromatography
- HDLc
- high density lipoprotein cholesterol
- LA
- linoleic acid
- LASSO
- least absolute shrinkage and selection operator
- LC
- liquid chromatography
- LDLc
- low density lipoprotein cholesterol
- LOX
- lipoxygenase
- MeOH
- methanol
- MetS
- metabolic syndrome
- MRM
- multiple reaction monitoring
- MS
- mass spectrometry
- MS/MS
- tandem mass spectrometry
- OA
- oleic acid
- OR
- odd ratio
- PMN
- polymorphonuclear
- PPARγ
- proliferator-activated receptor γ
- PUFAs
- polyunsaturated fatty acids
- PURE
- Prospective Urban and Rural Epidemiological
- QC
- quality control
- SD
- standard deviation
- sEH
- soluble epoxide hydrolase
- SPE
- solid phase extraction
- TG
- triglycerides
- VLDL
- very density lipoprotein cholesterol
- WC
- waist circumference.